Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 1294 entries
View as:

Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT01562821 Org: User:
Start: 07/31/01 End: 12/31/02 Due: 12/31/03

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02963922 Org: User:
Start: 02/06/17 End: 09/25/18 Due: 09/25/19

A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05127473 Org: User:
Start: 07/14/21 End: 05/14/22 Due: 05/14/23

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01647451 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00825643 Org: User:
Start: 04/30/08 End: 03/31/11 Due: 03/31/12

A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India

Phase: N/A Priority: Normal
NCT ID: NCT05502562 Org: User:
Start: 02/24/23 End: 06/03/24 Due: 06/03/25

Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01486381 Org: User:
Start: 03/20/02 End: 05/30/03 Due: 05/30/04

Evaluating the Use of Two Different Needles in Subjects With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00569426 Org: User:
Start: 04/30/05 End: 06/30/05 Due: 06/30/06

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00469586 Org: User:
Start: 04/26/07 End: 04/24/08 Due: 04/24/09

Comparison of Two Insulin Detemir Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01498926 Org: User:
Start: 11/30/05 End: 02/28/06 Due: 02/28/07

Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00568984 Org: User:
Start: 11/21/02 End: 11/10/03 Due: 11/10/04

A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02844790 Org: User:
Start: 07/26/16 End: 09/27/16 Due: 09/27/17

A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04012255 Org: User:
Start: 07/15/19 End: 10/22/19 Due: 10/22/20

Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

Phase: N/A Priority: Normal
NCT ID: NCT05040971 Org: User:
Start: 09/06/21 End: 07/14/23 Due: 07/14/24

A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

Phase: N/A Priority: Normal
NCT ID: NCT05718570 Org: User:
Start: 02/03/23 End: 12/15/32 Due: 12/15/33

Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02607865 Org: User:
Start: 02/15/16 End: 03/28/18 Due: 03/28/19

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT02835235 Org: User:
Start: 07/26/16 End: 07/07/17 Due: 07/07/18

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02825251 Org: User:
Start: 07/06/16 End: 07/21/17 Due: 07/21/18

Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02536859 Org: User:
Start: 08/31/15 End: 04/14/16 Due: 04/14/17

A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06737536 Org: User:
Start: 12/18/24 End: 07/25/25 Due: 07/25/26

Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00184678 Org: User:
Start: 02/28/02 End: 07/31/06 Due: 07/31/07

Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01868581 Org: User:
Start: 05/31/08 End: 08/31/08 Due: 08/31/09

Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01405261 Org: User:
Start: 08/31/11 End: 05/31/12 Due: 05/31/13

Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01923181 Org: User:
Start: 12/02/13 End: 12/11/14 Due: 12/11/15

Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01618214 Org: User:
Start: 06/30/12 End: 01/31/13 Due: 01/31/14